Biocon Limited(BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the fiscal fourth quarter and the financial year ended March 31, 2024. Leadership Comments BIOCON GROUP “Q4FY24 performance was strongly led by ...
Tentative calendar for upcoming financial results 2024-25 Q1 FY 2024-25 Was released on August 9, 2024 Q2 FY 2024-25 Was released on October 30, 2024 Q3 FY 2024-25 Will be released on January 30, 2025 Q4 FY 2024-25 Will be released on May 8, 2025 ...